Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The MYB gene was originally a protooncogene that was isolated from avian myeloblastosis virus and expressed c-MYB transcription factor, and was homologous to the v-MYB gene in avian erythrocytosis virus. The human MYB gene is located on the 24th region of the long arm of chromosome 6 and consists of three major components: the N-terminal recognition consensus sequence PyAACG /TG DNA binding domain, the C-terminal negative regulatory domain responsible for regulating protein expression and the central part responsible for locating the domain of transcriptional activation. Through human genome detection, it currently includes pro-proliferation genes MYC, c-KIT, CCNA1, CCNB1, CCNE1; anti-apoptotic gene Bcl-2, heat shock protein 70, heat shock protein A5; differentiation regulatory gene GATA binding protein 3, etc.
Figure 1. The potential CPC-MYC1-TTG1 regulatory complex in cotton. (Bingliang, L., et al. 2015)
Correlation between MYB and Plant Growth and Development
MYB transcription factors have a variety of biological functions and are widely involved in the growth and development of plant roots, stems, leaves and flowers. Moreover, the MYB gene family also responds to abiotic stresses such as drought, salt and cold damage, In addition, MYB transcription factors are also closely related to the quality of certain cash crops. Studies have found that plants, roots, stems, leaves, flowers, fruits and other organs and tissues have expression of MYB transcription factor-related genes. At present, MYB transcription factors are more comprehensive in the study of the regulation of cell morphology and pattern. The regulation of MYB transcription factors is important in the process of plant root hair formation. MYB transcription factors are closely related to the development of plant glandular hairs, and MYB transcription factors can be used to improve fiber quality. For example, the length of the cotton fiber is increased by adjusting the expression level of the gene controlling the quality of the cotton fiber.
Subcellular localization analysis of the MYB protein family revealed that the gene expression product is in the nucleus. The StR2R3-MYB transcription factor in potato was subcellularly localized and transiently expressed in Arabidopsis protoplasts. Under confocal scanning microscopy, the fusion protein was found to be localized in the nucleus. The MYB transcription factor plays a major role in the secondary metabolism of plants in the phenylpropanoid metabolic pathway. The starting material of this pathway, shikimic acid, produces phenylalanine via the shikimate pathway, and phenylalanine is in the rate-limiting enzyme. Under the action of phenylalanine ammonia-lyase, many different secondary metabolites are produced. The synthesis of anthocyanins and flavonoids in these secondary products is closely related to MYB transcription factors, which are also plants. A substrate for pigment synthesis, so the MYB transcription factor regulates flower color and fruit color.
The Role of MYB in Tumorigenesis
MYB not only plays an important role in the regulation of proliferation, mutation and apoptosis of hematopoietic system, colon and brain structural cells, but also participates in tumor formation. It is overexpressed in malignant tumors such as liver cancer, breast cancer, colorectal cancer, and leukemia. Expression of MYB inhibits the differentiation of cancer cells, and its overexpression is only present in immature or proliferating cells, and its presence is generally not detected in normal tissues or in differentiated cells. Abnormal MYB expression is an effective driver of neoplasia in animal and human malignancies.
The first evidence for the carcinogenic potential of MYB is the discovery that the v-MYB viral oncogene can induce myeloblast transformation in chickens and baboons. v-MYB represents a truncated form of the MYB gene, and its leukemia potential is related to the deletion and mutation of its C-terminal regulatory domain. Subsequent studies have detected MYB overexpression in most human bone marrow and acute lymphoblastic leukemias, and changes in activity in hematological malignancies are often associated with recurrent chromosomal aberrations, such as amplification, promoter rearrangement.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.